Prime Medicine
PRME
PRME
105 hedge funds and large institutions have $433M invested in Prime Medicine in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 27
8% less capital invested
Capital invested by funds: $472M → $433M (-$39M)
33% less call options, than puts
Call options by funds: $375K | Put options by funds: $558K
Holders
105
Holding in Top 10
2
Calls
$375K
Puts
$558K
Top Buyers
| 1 | +$4.57M | |
| 2 | +$3.93M | |
| 3 | +$3.37M | |
| 4 |
BG
Bollard Group
Boston,
Massachusetts
|
+$3.2M |
| 5 |
Two Sigma Investments
New York
|
+$1.55M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$8.21M | |
| 3 | -$5.72M | |
| 4 |
MCM
Moore Capital Management
New York
|
-$4.26M |
| 5 |
Rafferty Asset Management
New York
|
-$1.23M |